CITATION — REFERENCE ENTRY

Papulopustular infantile acne treated with oral isotretinoin — Anais Brasileiros de Dermatologia

Revision 14037800-5949-4816-9e6a-bb7b650e720e · 10/6/2026, 3:25:07 PM UTC
Key
santos-2023-papulopustular-infantile-acne
Authors
Santos, Grasielle Silva; Ianhez, Mayra; Miot, Hélio Amante
Issued
2023
Type
article-journal
Container
Anais Brasileiros de Dermatologia
Raw CSL JSON
{
  "DOI": "10.1016/j.abd.2021.05.026",
  "URL": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10173067/",
  "type": "article-journal",
  "title": "Papulopustular infantile acne treated with oral isotretinoin",
  "author": [
    {
      "given": "Grasielle Silva",
      "family": "Santos"
    },
    {
      "given": "Mayra",
      "family": "Ianhez"
    },
    {
      "given": "Hélio Amante",
      "family": "Miot"
    }
  ],
  "issued": {
    "date-parts": [
      [
        2023
      ]
    ]
  },
  "container-title": "Anais Brasileiros de Dermatologia"
}

Claims

  1. Santos and colleagues note that oral isotretinoin is off-label at this age, that published doses range from 0.2 to 2.0 mg/kg/day over five to 14 months of treatment, and that androgen testing is mandatory in refractory cases although most are not related to underlying endocrine disease.
    "The oral isotretinoin dose for infantile acne varies among publications between 0.2 and 2.0 mg/kg/day, with a total treatment period of five up to 14 months."
    Quote language: en
Available in